Evidence map›Paper›PMID 34136390›Full record

ArticleFrontiers in oncology2021

Sumei Yao, Ayse Ertay, Yilu Zhou, Liudi Yao, Charlotte Hill, Jinliang Chen, Yangbo Guan, Hui Sun, Rob M Ewing, Yifei Liu and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Sumei YaoDepartment of Respiratory Medicine, The Second Affiliated Hospital of Nantong University, Nantong, China.
Ayse ErtayBiological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, United Kingdom.
Yilu ZhouBiological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, United Kingdom.
Liudi YaoBiological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, United Kingdom.
Charlotte HillBiological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, United Kingdom.
Jinliang ChenDepartment of Respiratory Medicine, The Second Affiliated Hospital of Nantong University, Nantong, China.
Yangbo GuanDepartment of Urology, Affiliated Hospital of Nantong University, Nantong, China.
Hui SunDepartment of Pathology, Affiliated Hospital of Nantong University, Nantong, China.
Rob M EwingBiological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, United Kingdom.
Yifei LiuDepartment of Pathology, Affiliated Hospital of Nantong University, Nantong, China.
Xuedong LvDepartment of Respiratory Medicine, The Second Affiliated Hospital of Nantong University, Nantong, China.
Yihua WangBiological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, United Kingdom.
University of Southampton · GBAffiliated Hospital of Nantong University · CNNantong University · CNSecond Affiliated Hospital of Nantong University

Funding

Medical Research Council MR/S025480/1
6 · The paper itself

Abstract

G protein-coupled receptor kinase 6 (GRK6) is expressed in various tissues and is involved in the development of several diseases including lung cancer. We previously reported that GRK6 is down-regulated in lung adenocarcinoma patients, which induces cell invasion and metastasis. However, further understanding of the role of GRK6 in lung adenocarcinoma is required. Here we explored the functional consequence of

Indexed as

EMTGRK6HIFhypoxialung adenocarcinoma

Identifiers

PMID34136390
PMCPMC8201516
OpenAlexW3171397763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.